Literature DB >> 18363508

Cerebral apoptosis in severe traumatic brain injury patients: an in vitro, in vivo, and postmortem study.

Eduardo Miñambres1, Maria Angeles Ballesteros, Marta Mayorga, Maria José Marin, Pedro Muñoz, Javier Figols, Marcos López-Hoyos.   

Abstract

One of the most important recent observations in traumatic brain injury (TBI) relates to the potential role of apoptosis in secondary brain injury. We aimed to analyze the presence of apoptosis and the expression of apoptosis-related proteins in brain samples from patients with TBI. We also tried to find any association between the in situ results and the in vitro observations in a neuronal model of induced-apoptosis. Brain tissue from the pericontusional zone (PCZ) of patients with traumatic contusions and from post-mortem samples was analyzed. Immunohistochemical analyses of apoptosis-related proteins and the terminal deoxynucleotide transferase-mediated nick end labeling (TUNEL) method to determine the presence of apoptotic cells were performed. Apoptotic rates on neuronal cells induced by jugular bulb vein sera was determined by flow cytometry. TUNEL-positive cells were detected in all PCZ of traumatic contusions and in most of PCZ in post-mortem specimens (none in control; p = 0.026). In vivo samples showed higher expression of antiapoptotic proteins Bcl-2 (p = 0.027) and Bcl-XL (p = 0.014) than post-mortem samples. In autopsies, the expression of Fas and Bim (p < 0.05) were higher in PCZ than in the zone distal from the contusion. In vitro studies showed that apoptotic rate was an independent factor associated with mortality at 6 months (p = 0.014). In the receiving operator curve (ROC) curve, a cut-off point of 66.5% showed a sensitivity of 89.5% and specificity of 66.7% in the prediction of patients' death. Cerebral apoptosis is a prominent form of cell death in the PCZ of human traumatic cerebral contusions, and high rates of in vitro apoptosis are associated with a poorer prognosis after TBI.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18363508     DOI: 10.1089/neu.2007.0398

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  28 in total

1.  BCL2 genotypes: functional and neurobehavioral outcomes after severe traumatic brain injury.

Authors:  Nicole Zangrilli Hoh; Amy K Wagner; Sheila A Alexander; Robert B Clark; Sue R Beers; David O Okonkwo; Dianxu Ren; Yvette P Conley
Journal:  J Neurotrauma       Date:  2010-08       Impact factor: 5.269

2.  Brain maturation in neonatal rodents is impeded by sevoflurane anesthesia.

Authors:  Rany Makaryus; Hedok Lee; Tian Feng; June-Hee Park; Maiken Nedergaard; Zvi Jacob; Grigori Enikolopov; Helene Benveniste
Journal:  Anesthesiology       Date:  2015-09       Impact factor: 7.892

3.  The metastasis-promoting S100A4 protein confers neuroprotection in brain injury.

Authors:  Oksana Dmytriyeva; Stanislava Pankratova; Sylwia Owczarek; Katrin Sonn; Vladislav Soroka; Christina M Ridley; Alexander Marsolais; Marcos Lopez-Hoyos; Noona Ambartsumian; Eugene Lukanidin; Elisabeth Bock; Vladimir Berezin; Darya Kiryushko
Journal:  Nat Commun       Date:  2012       Impact factor: 14.919

Review 4.  Application of Tauroursodeoxycholic Acid for Treatment of Neurological and Non-neurological Diseases: Is There a Potential for Treating Traumatic Brain Injury?

Authors:  Kyle R Gronbeck; Cecilia M P Rodrigues; Javad Mahmoudi; Eric M Bershad; Geoffrey Ling; Salam P Bachour; Afshin A Divani
Journal:  Neurocrit Care       Date:  2016-08       Impact factor: 3.210

5.  Pathophysiology and Treatment of Severe Traumatic Brain Injuries in Children.

Authors:  Kimberly A Allen
Journal:  J Neurosci Nurs       Date:  2016-02       Impact factor: 1.230

Review 6.  In vivo contributions of BH3-only proteins to neuronal death following seizures, ischemia, and traumatic brain injury.

Authors:  Tobias Engel; Nikolaus Plesnila; Jochen H M Prehn; David C Henshall
Journal:  J Cereb Blood Flow Metab       Date:  2011-03-02       Impact factor: 6.200

7.  Protective Effects of Cornel Iridoid Glycoside in Rats After Traumatic Brain Injury.

Authors:  Denglei Ma; Na Wang; Xiaotong Fan; Lan Zhang; Yi Luo; Rui Huang; Li Zhang; Yali Li; Guoguang Zhao; Lin Li
Journal:  Neurochem Res       Date:  2018-02-28       Impact factor: 3.996

8.  Suppression of the intrinsic apoptosis pathway by synaptic activity.

Authors:  Frédéric Léveillé; Sofia Papadia; Michael Fricker; Karen F S Bell; Francesc X Soriano; Marc-André Martel; Clare Puddifoot; Marlen Habel; David J Wyllie; Chrysanthy Ikonomidou; Aviva M Tolkovsky; Giles E Hardingham
Journal:  J Neurosci       Date:  2010-02-17       Impact factor: 6.167

Review 9.  Cell death mechanisms and modulation in traumatic brain injury.

Authors:  Bogdan A Stoica; Alan I Faden
Journal:  Neurotherapeutics       Date:  2010-01       Impact factor: 7.620

10.  Erythropoietin improves histological and functional outcomes after traumatic brain injury in mice in the absence of the neural erythropoietin receptor.

Authors:  Ye Xiong; Asim Mahmood; Changsheng Qu; Humaira Kazmi; Zheng Gang Zhang; Constance T Noguchi; Timothy Schallert; Michael Chopp
Journal:  J Neurotrauma       Date:  2010-01       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.